Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP410130.RAR3xnFYPwx0xBxInzZzeXNVA5MxjNzq3WK-CT6JykOg4130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410130.RAR3xnFYPwx0xBxInzZzeXNVA5MxjNzq3WK-CT6JykOg4130_provenance.
• NP963322.RAdPz_RlR4UUHMiV9EKy0lActKPyO1BALGwvSFwigfSo8130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP963322.RAdPz_RlR4UUHMiV9EKy0lActKPyO1BALGwvSFwigfSo8130_provenance.
• NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968949.RATwcPnICYcPWKNvmOuTipQ6RU0X7htrpYkynwl5_Z_As130_provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP800675.RAeDQY1def147wPet5G3vmLQORpglKrDQ4svQC_2tGVRk130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800675.RAeDQY1def147wPet5G3vmLQORpglKrDQ4svQC_2tGVRk130_provenance.
• NP800676.RAQSg8jNauGy14NRmZ3IDc7oYq_CryY6yhpGlzdaakwNw130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800676.RAQSg8jNauGy14NRmZ3IDc7oYq_CryY6yhpGlzdaakwNw130_provenance.
• NP800677.RAVSd8zJ6_iVUwVRm75WA6CDvEXc56xXtNaGRPqeI5kEE130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800677.RAVSd8zJ6_iVUwVRm75WA6CDvEXc56xXtNaGRPqeI5kEE130_provenance.
• NP800682.RAcYVNBO3PXnGF4DRx13ccoYK2aFLZTsg_dO7WdFPki7M130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800682.RAcYVNBO3PXnGF4DRx13ccoYK2aFLZTsg_dO7WdFPki7M130_provenance.
• NP800684.RAWW7vhHlQlsFGtxYvXGb2NYJuIkCEF1NlQvRWUzvrWoU130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800684.RAWW7vhHlQlsFGtxYvXGb2NYJuIkCEF1NlQvRWUzvrWoU130_provenance.
• NP800685.RAcAUFJ-72hiLNPkU2SocWxDBLBo14jNA0ilmjh3ahJ7E130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800685.RAcAUFJ-72hiLNPkU2SocWxDBLBo14jNA0ilmjh3ahJ7E130_provenance.
• NP800686.RAbu2FdDo9rBY-xacoJd5F6c7R7JQkzbOh8k99M8O-tEk130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800686.RAbu2FdDo9rBY-xacoJd5F6c7R7JQkzbOh8k99M8O-tEk130_provenance.
• NP800681.RABomYbWXw5T6PEPxIZa3CbkbcFAQASfH7Uxmv1onVQnc130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800681.RABomYbWXw5T6PEPxIZa3CbkbcFAQASfH7Uxmv1onVQnc130_provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP410066.RApyVnCv5AaHMzjvjlbzxUaJg3w26JDAYZOsM6TGh8SMQ130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410066.RApyVnCv5AaHMzjvjlbzxUaJg3w26JDAYZOsM6TGh8SMQ130_provenance.
• NP963304.RAokKXXnMUpyhGYXVbJhJ97IPhuek6IoSGbFDgb5unIls130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP963304.RAokKXXnMUpyhGYXVbJhJ97IPhuek6IoSGbFDgb5unIls130_provenance.
• NP968936.RAnR5twEoC0bfdw6qzJJtyPTtVJ-3KnOo5Kv_QkyuBM-I130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968936.RAnR5twEoC0bfdw6qzJJtyPTtVJ-3KnOo5Kv_QkyuBM-I130_provenance.
• NP885786.RAg-mABtgqzARkilh5101w5PYFBmDP6L6hwWeEWhBhDZ4130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885786.RAg-mABtgqzARkilh5101w5PYFBmDP6L6hwWeEWhBhDZ4130_provenance.
• NP800674.RAiBEiSwdsMGpDR7gQGNriZw93UFPQIPq_cu_4lQQqOBM130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800674.RAiBEiSwdsMGpDR7gQGNriZw93UFPQIPq_cu_4lQQqOBM130_provenance.
• NP409404.RA_ytkF_drM0A0zvXmZXvdBtvsnqy4CRdyLG5_M368BIU130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP409404.RA_ytkF_drM0A0zvXmZXvdBtvsnqy4CRdyLG5_M368BIU130_provenance.
• NP880510.RANM9zITLL89YfvtSXzO1DOKqLjhrIofwACN3rqq4mA4g130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880510.RANM9zITLL89YfvtSXzO1DOKqLjhrIofwACN3rqq4mA4g130_provenance.
• NP1015283.RAFuuGcAkYwvVR8r8cLVs_GfJ9FMFcRx604zUoHL0qX7E130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015283.RAFuuGcAkYwvVR8r8cLVs_GfJ9FMFcRx604zUoHL0qX7E130_provenance.
• NP1015301.RAOxy9JA2fpfYcYPKwPwxgY5U51GvB-24bVM10GHpFUkU130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015301.RAOxy9JA2fpfYcYPKwPwxgY5U51GvB-24bVM10GHpFUkU130_provenance.
• NP800680.RAHEz2j_s-onfsRR7Zm9snIXy73ImbBLFteAw2YHzBDEU130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800680.RAHEz2j_s-onfsRR7Zm9snIXy73ImbBLFteAw2YHzBDEU130_provenance.
• NP843477.RA0tod7esrGGuUFS_oN6ALWxNquHT8EFG6dyY_STZbkTM130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843477.RA0tod7esrGGuUFS_oN6ALWxNquHT8EFG6dyY_STZbkTM130_provenance.
• NP843495.RA7Z859BzU97-3ICJxE3Df3PIVssEDW4l6BR-Sx11oUTo130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843495.RA7Z859BzU97-3ICJxE3Df3PIVssEDW4l6BR-Sx11oUTo130_provenance.
• NP880524.RA9w1W7UzNky6RwKEVnU1KHmxn1TCr1hfifIm9dbY17KA130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880524.RA9w1W7UzNky6RwKEVnU1KHmxn1TCr1hfifIm9dbY17KA130_provenance.
• NP885768.RA_Pnd07H4u21sDVLxCwzGRwxY2sKnUStcWELBBtFVrLQ130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885768.RA_Pnd07H4u21sDVLxCwzGRwxY2sKnUStcWELBBtFVrLQ130_provenance.
• NP800678.RAzV18YD6HuTJStuCW0WT4sT88NC6qeKZSatDaGCf_iPc130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800678.RAzV18YD6HuTJStuCW0WT4sT88NC6qeKZSatDaGCf_iPc130_provenance.
• NP800679.RA1QZWvUoE8CWomnprIKDqT6ATBLp65gTYFiLQtO7VS8c130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800679.RA1QZWvUoE8CWomnprIKDqT6ATBLp65gTYFiLQtO7VS8c130_provenance.
• NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_assertion description "[Therefore, human SIP format antibodies against Fn ED-A, Fn ED-B and Tn-C A and C splice domains were used for immunofluorescence labelling in renal, lung, oral, colon, breast and urinary bladder carcinoma specimens and in a renal carcinoma xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800683.RA7SFCWU5pb4Q_6lMrKaiCpr4SWR89to1pNPO1UA4DG3k130_provenance.